Originally published October 4 2005
Editor promotes updating the 2004 Bioshield law
by Mike Adams, the Health Ranger, NaturalNews Editor
An editor at the Washington Times is calling for an update of the 2004 Bioshield law, designed to help preparations for a bioterrorist attack, and the recent admission by members of Congress that America is not prepared for an influenza epidemic, much less a large-scale bioterror event, seems to confirm the need for revised legislation.
The threat of the avian flu virus is real, as Senate Majority Leader Bill First explains in this section, and could potentially claim millions of American lives.
No vaccine for the avian flu exists.
The country needs biotechs, academia and government to cooperate to create the vaccines and other compounds needed to fight it.
To deal with the avian flu and the others -- anthrax, smallpox and radiological threats, to name three -- the United States must update the 2004 Bioshield law.
For instance, it took three years and eight months after the October 2001 anthrax attacks before the Department of Health and Human Services finally stockpiled the first doses of anthrax vaccine.
Beyond the obvious no-defenses problem, this was regrettable because it disheartened some biotechs and pharmaceutical firms considering supplying the government with new drugs to combat new biological threats.
Foot-dragging in Congress alternated with the same in the administration on anthrax, while an intense lobbying war simmered between BioPort, the Michigan-based maker of BioThrax, and California-based VaxGen, maker of a vaccine currently in trials.
As The Washington Post reported yesterday, Hollis-Eden Pharmaceuticals, maker of a radiological countermeasure, is complaining about foot-dragging on Neumune, which, if successful, would greatly lessen radiation sickness -- the primary threat in the event of a "dirty bomb."
Government sloth "has basically killed the capital markets and ability to raise money to develop these drugs."
On the avian flu, Mr. Frist lamented the lack of "an effective vaccine and a robust antiviral stockpile" in a Tuesday letter to Secretary of Health and Human Services Mike Leavitt, noting that each problem is "complicated by a weakened domestic manufacturing capacity."
The common theme here is that government is not doing enough to create favorable conditions for companies building the compounds we need.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml